NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.550
+0.030 (1.97%)
Aug 19, 2026, 12:38 PM EDT - Market open
NuCana Market Cap
NuCana has a market cap or net worth of $6.45 million as of August 19, 2026. Its market cap has increased by 6,350.90% in one year.
Market Cap
6.45M
Enterprise Value
-18.53M
1-Year Change
6,350.90%
Ranking
Category
Stock Price
$1.55
ChartMarket Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $6.45M, a decrease of -98.74%. That is a compound annual growth rate of -38.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 6.45M | -56.99% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 7.06M |
| Ernexa Therapeutics | 6.97M |
| Evogene | 6.73M |
| AIM ImmunoTech | 6.69M |
| Processa Pharmaceuticals | 6.68M |
| XTL Biopharmaceuticals | 6.65M |
| Bolt Biotherapeutics | 6.45M |
| Liminatus Pharma | 6.28M |